Michael Quante

Michael Quante is an experienced medical professional currently serving as an Oberarzt and W3 Professor at Universitätsklinikum Freiburg since October 2020. At this institution, Michael Quante leads a laboratory focused on translational research concerning Barrett's Esophagus and esophageal adenocarcinoma, emphasizing the role of gastrointestinal stem cells in inflammation-induced carcinogenesis. The primary objective is to advance the clinical application of foundational scientific principles to enhance the care and treatment of esophageal cancer patients and improve surveillance for those with Barrett's Esophagus. Prior to this role, Michael Quante was an Oberarzt at Technische Universität München from May 2011 to October 2020, and also worked as an MD and Principal Investigator at the Tumor Microenvironment Network within the National Cancer Institute in 2011.